9 standard-of-care settings across 4 lines and 3 biomarker subgroups. Rows come from the cancer page's standard of care; the grid places each on its line and subgroup.
MRI with contrast; maximal safe resection with 5-ALA and intraoperative mapping; integrated histo-molecular diagnosis with methylation classification where available.
Radiotherapy60 Gy (hypofractionated in elderly) with concurrent and 6 cyclesadjuvanttemozolomide; TTFields with maintenance temozolomide; trials for MGMT-unmethylated patients.
Re-resection or LITT if feasible; lomustine; bevacizumab for oedema/steroid sparing; re-irradiation; clinical trial (CAR-T, FUS-BBB, vaccines) strongly preferred.
Resection where safe; chemotherapy (carboplatin/vincristine) or tovorafenib / dabrafenib-trametinib for BRAF-altered relapsed disease; avoid radiation in young children.
Lines and subgroups are parsed from the setting text of each standard-of-care row and can misclassify an unusual phrasing; the row’s own setting is always shown. Guideline chips reflect the NCCN category and ESMO-MCBS grade recorded on the cancer page, checked on its stated date. Not medical advice.